A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain-Reference-Cited by-同舟云学术

A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain

Published:2016-04-13 Issue:6 Volume:27 Page:384-391
ISSN:0959-4965
Container-title:NeuroReport
language:en
Short-container-title:

Author:

Cao Lijun,Li Dongfang,Feng Peng,Li Lin,Xue Guo-Fang,Li Guanglai,Hölscher Christian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Neuroscience

Reference38 articles.

1. Parkinsons disease: current and future challenges.;Langston;Neurotoxicology,2002

2. GDNF family ligands: a potential future for Parkinsons disease therapy.;Mickiewicz;CNS Neurol Disord Drug Targets,2011

3. Insulin, incretins and other growth factors as potential novel treatments for Alzheimers and Parkinsons diseases.;Holscher;Biochem Soc Trans,2014

4. A new Alzheimers disease interventive strategy: GLP-1.;Perry;Curr Drug Targets,2004

5. Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases.;Holscher;J Endocrinol,2014

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease;European Journal of Pharmacology;2024-11

2. Time association study on a sub-acute mouse model of Parkinson’s disease;Heliyon;2024-07

3. The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade;International Immunopharmacology;2024-06

4. GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease;International Journal of Molecular Sciences;2024-03-29

5. Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats;International Journal of Molecular Sciences;2024-03-05